Clinical course of the patient with malignant pheochromocytoma who was treated on cvd chemotherapy and α-methyl-p-tyrosine

0Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A 31-years-old woman was diagnosed as pheocromocytoma by the various endocrine testings and 131I-MIBG scintigraphy. The CT scan and bone scintigraphy showed right adrenal tumor, along with liver metastasis, lymph nodes swelling around aorta and multiple bone metastases. She underwent chemotherapy consisting with Cyclophosphamide, Vincristine, Dacarbazine (CVD) and α-methyl-p-tyrosine (αMT), resulting in stable disease for 27 months. However, catecholamine levels increased gradually four weeks later. We would have planned 131I-MIBG therapy, but bone marrow suppression did not allow us to do it She died of DIC. © 2010 Japanese Urological Association.

Cite

CITATION STYLE

APA

Nagata, M., Takayama, T., Nishijima, N., Mugiya, S., Ushiyama, T., & Ozono, S. (2010). Clinical course of the patient with malignant pheochromocytoma who was treated on cvd chemotherapy and α-methyl-p-tyrosine. Japanese Journal of Urology, 101(4), 615–618. https://doi.org/10.5980/jpnjurol.101.615

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free